Pluristem Therapeutics Inc.

PSTI · NASDAQ
Analyze with AI
6/30/2025
6/30/2021
6/30/2020
6/30/2019
Operating Activities
Net Income-$23,250-$49,865-$29,152-$35,307
Dep. & Amort.$316$1,370$1,570$1,962
Deferred Tax$0$0$0$0
Stock-Based Comp.$2,143$13,968$2,562$5,146
Change in WC$0$3,665-$1,338-$1,251
Other Non-Cash$2,580-$48-$11-$3
Operating Cash Flow-$18,211-$30,910-$26,369-$29,453
Investing Activities
PP&E Inv.-$1,618-$373-$270-$239
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0-$30,188$0
Inv. Sales/Matur.$0$0$0$1,415
Other Inv. Act.$9,644-$6,892$0-$6
Investing Cash Flow$8,026-$7,265-$30,458$1,170
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$0$36,589$58,163$23,467
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$9,533$61,402$60,870$23,582
Financing Cash Flow$9,533$61,402$60,870$23,582
Forex Effect-$1,055-$618$0$0
Net Chg. in Cash-$475$22,609$4,043-$4,701
Supplemental Information
Beg. Cash$7,671$9,229$5,186$9,887
End Cash$7,196$31,838$9,229$5,186
Free Cash Flow-$19,829-$31,283-$26,639-$29,692